Experimental Cancer Drug Navitoclax Shows Promise in Enhancing Tuberculosis Treatment and Reducing Lung Damage
In a significant advancement for global infectious disease research, investigators at Johns Hopkins Medicine have...
Knowledge and News for the Global Fight Against Cancer.
In a significant advancement for global infectious disease research, investigators at Johns Hopkins Medicine have...
A groundbreaking study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) reveals...
In a landmark achievement for pediatric oncology, a multi-institutional research initiative led by the Biocenter...
A groundbreaking preclinical study, spearheaded by investigators at Weill Cornell Medicine, has identified linoleic acid,...
A collaborative international study led by the Johns Hopkins Kimmel Cancer Center’s Bloomberg~Kimmel Institute for...
The complex decision of initiating hormone therapy (HT) during the perimenopausal and postmenopausal transition, a...
The global oncology community has long grappled with the inherent limitations of conventional chemotherapy, particularly...
Approximately 25% of women in the United States between the ages of 45 and 60...
New research from the University of South Australia has revealed a concerning link between the...
Understanding Interval Breast Cancers: A Critical Challenge in Early Detection Breast cancer remains one of...